PXVX0317
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for PXVX0317, covering 2023-02-28 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination [Phase 3]